149 related articles for article (PubMed ID: 21173136)
41. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
Renshaw AA
Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
[TBL] [Abstract][Full Text] [Related]
42. Hürthle cell metaplasia in chronic lymphocytic thyroiditis: Role of age factor and review of literature on its molecular pathogenesis.
Das DK
Diagn Cytopathol; 2019 May; 47(5):475-481. PubMed ID: 30588770
[TBL] [Abstract][Full Text] [Related]
43. Cytoplasmic colloid inclusions in thyroid lesions: a cytomorphological study based on fine needle aspiration.
Das DK; Pathan SK; Francis IM; Sheikh ZA; Al-Juwaiser A; Shaheen A; Prabha K; George J; Kapila K
Cytopathology; 2005 Oct; 16(5):233-9. PubMed ID: 16181309
[TBL] [Abstract][Full Text] [Related]
44. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases.
Seningen JL; Nassar A; Henry MR
Diagn Cytopathol; 2012 May; 40 Suppl 1():E27-32. PubMed ID: 22619156
[TBL] [Abstract][Full Text] [Related]
45. Subclassification of "atypia of undetermined significance" in thyroid fine-needle aspirates.
Wu HH; Inman A; Cramer HM
Diagn Cytopathol; 2014 Jan; 42(1):23-9. PubMed ID: 24166935
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation.
Deandrea M; Ragazzoni F; Motta M; Torchio B; Mormile A; Garino F; Magliona G; Gamarra E; Ramunni MJ; Garberoglio R; Limone PP
Thyroid; 2010 Oct; 20(10):1077-83. PubMed ID: 20883171
[TBL] [Abstract][Full Text] [Related]
47. Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.
Yuan L; Nasr C; Bena JF; Elsheikh TM
Diagn Cytopathol; 2022 Sep; 50(9):424-435. PubMed ID: 35674254
[TBL] [Abstract][Full Text] [Related]
48. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
McKee S; Wu H; Wang X; Cramer H; Lin J; Chen S
Acta Cytol; 2014; 58(3):235-8. PubMed ID: 24819535
[TBL] [Abstract][Full Text] [Related]
49. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
Renshaw AA; Gould EW
Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
[TBL] [Abstract][Full Text] [Related]
50. Pretransplant Thyroid Findings in Patients With End-Stage Renal Disease.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Özgün G; Kazancı S; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):67-70. PubMed ID: 27805516
[TBL] [Abstract][Full Text] [Related]
51. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
52. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
53. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
Wu HH; Clouse J; Ren R
Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
[TBL] [Abstract][Full Text] [Related]
54. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
Montone KT; Baloch ZW; LiVolsi VA
Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
[TBL] [Abstract][Full Text] [Related]
55. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
56. Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations: Follow-Up and Outcome Experience in Newfoundland, Canada.
Erivwo P; Ghosh C
Acta Cytol; 2018; 62(2):85-92. PubMed ID: 29486467
[TBL] [Abstract][Full Text] [Related]
57. Follicular and Hürthle cell lesions of the thyroid: can inconclusive results be minimized?
Sherman JF; Leiman G; Naud S; Nathan MH; Ambaye AB
Acta Cytol; 2008; 52(6):659-64. PubMed ID: 19068668
[TBL] [Abstract][Full Text] [Related]
58. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
59. Clinical Significance of Multinodularity in Patients with Papillary Thyroid Carcinoma.
Kust D; Mateša N; Kusić Z
Anticancer Res; 2015 Nov; 35(11):6335-9. PubMed ID: 26504073
[TBL] [Abstract][Full Text] [Related]
60. Thyroid fine needle aspiration cytology in children and adolescents.
Moslavac S; Matesa N; Kusić Z
Coll Antropol; 2010 Mar; 34(1):197-200. PubMed ID: 20432751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
